UMediC Group Berhad

KLSE:UMC Stock Report

Market Cap: RM 220.6m

UMediC Group Berhad Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Taw Lim

Chief executive officer

RM 441.0k

Total compensation

CEO salary percentage62.1%
CEO tenure3.8yrs
CEO ownership5.1%
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

Recent updates

UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business

Nov 11
UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business

UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns

Aug 05
UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns

We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings

Jun 17
We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings

UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality

Dec 18
UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality

Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)

Dec 12
Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)

Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital

Aug 11
Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital

Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)

Mar 13
Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)

Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?

Nov 25
Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?

CEO Compensation Analysis

How has Taw Lim's remuneration changed compared to UMediC Group Berhad's earnings?
DateTotal CompensationSalaryCompany Earnings
Oct 31 2024n/an/a

RM 9m

Jul 31 2024RM 441kRM 274k

RM 9m

Apr 30 2024n/an/a

RM 9m

Jan 31 2024n/an/a

RM 10m

Oct 31 2023n/an/a

RM 10m

Jul 31 2023n/an/a

RM 10m

Apr 30 2023n/an/a

RM 8m

Jan 31 2023n/an/a

RM 7m

Oct 31 2022n/an/a

RM 6m

Jul 31 2022RM 363kRM 228k

RM 6m

Jul 31 2021RM 891kRM 178k

RM 5m

Compensation vs Market: Taw's total compensation ($USD98.95K) is about average for companies of similar size in the MY market ($USD107.67K).

Compensation vs Earnings: Taw's compensation has been consistent with company performance over the past year.

CEO

Taw Lim (45 yo)

3.8yrs

Tenure

RM 441,000

Compensation

Mr. Taw Seong Lim serves as the Chief Executive Officer at UMediC Group Berhad and its an Executive Director since April 22, 2021. He began his career in 2002 with UMediC (formerly known as UWC Healthcar...

Board Members

NamePositionTenureCompensationOwnership
Taw Lim
CEO & Executive Director3.8yrsRM 441.00k5.11%
MYR 11.3m
Chai Ng
Non-Independent Non-Executive Chairman3.3yrsRM 61.00k5.54%
MYR 12.2m
Yee Lee
Independent Non-Executive Director3.3yrsRM 30.50k0.080%
MYR 177.0k
Pakirisamy Baskaran
Independent Non-Executive Director3.3yrsRM 30.50k0.080%
MYR 177.0k
Chye Tan
Independent Non-Executive Director3.3yrsRM 30.50k0.080%
MYR 177.0k
Sze Ng
Alternate Director1.8yrsRM 113.40k0.080%
MYR 177.0k
Keng Teh
Non Executive Independent Director1.3yrsRM 25.50kno data

3.3yrs

Average Tenure

55yo

Average Age

Experienced Board: UMC's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 23:39
End of Day Share Price 2025/01/31 00:00
Earnings2024/10/31
Annual Earnings2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

UMediC Group Berhad is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ken-Wern LimAffin Hwang Investment Bank
Siu Li ChuaHong Leong Investment Bank Berhad
Chee SiangHong Leong Investment Bank Berhad